We've found
184,457
clinical trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Other Clinical Trial
Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Aging Frailty Clinical Trial
Human Mesenchymal Stem Cells (LMSCs) on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Aging Frailty Clinical Trial
Human Mesenchymal Stem Cells (LMSCs) on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Clinical Trial
Taste Bud-Derived Stem Cells in Humans
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Efficacy of a Computerized Cognitive Behavioral Treatment for Insomnia: Increasing Access to Insomnia Treatment to Decrease Suicide Risk
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology Clinical Trial
Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
Status: Enrolling
Updated: 12/7/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Other, Reproductive Clinical Trial
Ideal Time of Oxytocin Infusion During Cesarean Section
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Childhood Absence Epilepsy Clinical Trial
Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors
Status: Enrolling,
Phase
II
Updated: 3/5/2018
Click here to add this to my saved trials
Autism Spectrum Disorder Clinical Trial
Investigating Social Competence in Youth With Autism
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Regional Anesthesia Morbidity Clinical Trial
Caudal Blockade and Electrocardiographic Changes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
TAS102 in Combination With NAL-IRI in Advanced GI Cancers
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
A Proof of Concept Study for 6 Month Treatment in Patients With C3 Glomerulopathy (C3G)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
The Microenvironment in Barrett's Esophagus
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology, Other Clinical Trial
Aging and Cognitive Health Evaluation in Elders (ACHIEVE)
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Psychiatry / Psychology, Other Clinical Trial
Aging and Cognitive Health Evaluation in Elders (ACHIEVE)
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Blood Biomarker of Alzheimer's Disease (AD)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Effectiveness of CES on Emotional and Cellular Wellbeing
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Adrenocortical Carcinoma Clinical Trial
Cabozantinib in Unresectable/Metastatic Adrenocortical Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status: Enrolling,
Phase
II
Updated: 5/1/2018
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status: Enrolling,
Phase
II
Updated: 5/1/2018
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Age Related Macular Degeneration Clinical Trial
Visual Function Tests in Age-related Macular Degeneration
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Other Clinical Trial
Bioenergetics and Muscle Function Improvement With AMAZ-02 in Elderly Skeletal Muscle (ENERGIZE Trial)
Status: Enrolling
Updated: 3/15/2018
Click here to add this to my saved trials
Endocrinology Clinical Trial
Diabetes Risk Education and Communication Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Daratumumab, Ixazomib, and Dexamethasone in Previously Treated Amyloid Light Chain (AL) Amyloidosis
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
PriMatrix for the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
PriMatrix for the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
AMPLATZER Duct Occluder II Additional Sizes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
AMPLATZER Duct Occluder II Additional Sizes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
AMPLATZER Duct Occluder II Additional Sizes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Abdominal Aneurysm Clinical Trial
Preferences for Open Vs. Endovascular Repair for Aortic Abdominal Aneurysm
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Abdominal Aneurysm Clinical Trial
Preferences for Open Vs. Endovascular Repair for Aortic Abdominal Aneurysm
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Abdominal Aneurysm Clinical Trial
Preferences for Open Vs. Endovascular Repair for Aortic Abdominal Aneurysm
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Substance Use Disorders Clinical Trial
Activating Community Support for Substance Users
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematological Malignancy Clinical Trial
A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematological Malignancy Clinical Trial
A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematological Malignancy Clinical Trial
A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematological Malignancy Clinical Trial
A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
184,457
clinical trials
Oncology Clinical Trial
Updated: 12/31/1969
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Other Clinical Trial
Updated: 12/31/1969
Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Aging Frailty Clinical Trial
Updated: 12/31/1969
Human Mesenchymal Stem Cells (LMSCs) on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Aging Frailty Clinical Trial
Updated: 12/31/1969
Human Mesenchymal Stem Cells (LMSCs) on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 12/31/1969
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Neurology, Other Clinical Trial
Updated: 12/31/1969
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Clinical Trial
Updated: 12/31/1969
Taste Bud-Derived Stem Cells in Humans
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Efficacy of a Computerized Cognitive Behavioral Treatment for Insomnia: Increasing Access to Insomnia Treatment to Decrease Suicide Risk
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Neurology Clinical Trial
Updated: 12/7/2017
Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
Status: Enrolling
Updated: 12/7/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Other, Reproductive Clinical Trial
Updated: 12/31/1969
Ideal Time of Oxytocin Infusion During Cesarean Section
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials
Childhood Absence Epilepsy Clinical Trial
Updated: 12/31/1969
Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Stage II Prostate Adenocarcinoma Clinical Trial
Updated: 12/31/1969
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 3/5/2018
Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors
Status: Enrolling,
Phase
II
Updated: 3/5/2018
Click here to add this to my saved trials
Autism Spectrum Disorder Clinical Trial
Updated: 12/31/1969
Investigating Social Competence in Youth With Autism
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Regional Anesthesia Morbidity Clinical Trial
Updated: 12/31/1969
Caudal Blockade and Electrocardiographic Changes
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
TAS102 in Combination With NAL-IRI in Advanced GI Cancers
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced Cancer Clinical Trial
Updated: 12/31/1969
An Investigational Immunotherapy Study of BMS-986249 Alone and in Combination With Nivolumab in Solid Cancers That Are Advanced or Have Spread
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Clinical Trial
Updated: 12/31/1969
A Proof of Concept Study for 6 Month Treatment in Patients With C3 Glomerulopathy (C3G)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 4/23/2018
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 4/23/2018
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 4/23/2018
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 4/23/2018
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 4/23/2018
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 4/23/2018
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 4/23/2018
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 4/23/2018
EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study)
Status: Enrolling,
Phase
IV
Updated: 4/23/2018
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
The Microenvironment in Barrett's Esophagus
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology, Other Clinical Trial
Updated: 1/19/2018
Aging and Cognitive Health Evaluation in Elders (ACHIEVE)
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Psychiatry / Psychology, Other Clinical Trial
Updated: 1/19/2018
Aging and Cognitive Health Evaluation in Elders (ACHIEVE)
Status: Enrolling
Updated: 1/19/2018
Click here to add this to my saved trials
Alzheimer Disease Clinical Trial
Updated: 12/31/1969
Blood Biomarker of Alzheimer's Disease (AD)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Psychiatry / Psychology Clinical Trial
Updated: 12/31/1969
Effectiveness of CES on Emotional and Cellular Wellbeing
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Adrenocortical Carcinoma Clinical Trial
Updated: 12/31/1969
Cabozantinib in Unresectable/Metastatic Adrenocortical Carcinoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 5/1/2018
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status: Enrolling,
Phase
II
Updated: 5/1/2018
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 5/1/2018
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status: Enrolling,
Phase
II
Updated: 5/1/2018
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Age Related Macular Degeneration Clinical Trial
Updated: 12/31/1969
Visual Function Tests in Age-related Macular Degeneration
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Other Clinical Trial
Updated: 3/15/2018
Bioenergetics and Muscle Function Improvement With AMAZ-02 in Elderly Skeletal Muscle (ENERGIZE Trial)
Status: Enrolling
Updated: 3/15/2018
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Diabetes Risk Education and Communication Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Study of Daratumumab, Ixazomib, and Dexamethasone in Previously Treated Amyloid Light Chain (AL) Amyloidosis
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
Updated: 12/31/1969
PriMatrix for the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetic Foot Ulcer Clinical Trial
Updated: 12/31/1969
PriMatrix for the Management of Diabetic Foot Ulcers
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
Updated: 12/31/1969
AMPLATZER Duct Occluder II Additional Sizes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
Updated: 12/31/1969
AMPLATZER Duct Occluder II Additional Sizes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Patent Ductus Arteriosus Clinical Trial
Updated: 12/31/1969
AMPLATZER Duct Occluder II Additional Sizes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Abdominal Aneurysm Clinical Trial
Updated: 12/31/1969
Preferences for Open Vs. Endovascular Repair for Aortic Abdominal Aneurysm
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Abdominal Aneurysm Clinical Trial
Updated: 12/31/1969
Preferences for Open Vs. Endovascular Repair for Aortic Abdominal Aneurysm
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Aortic Abdominal Aneurysm Clinical Trial
Updated: 12/31/1969
Preferences for Open Vs. Endovascular Repair for Aortic Abdominal Aneurysm
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Substance Use Disorders Clinical Trial
Updated: 12/31/1969
Activating Community Support for Substance Users
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hematological Malignancy Clinical Trial
Updated: 12/31/1969
A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematological Malignancy Clinical Trial
Updated: 12/31/1969
A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematological Malignancy Clinical Trial
Updated: 12/31/1969
A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematological Malignancy Clinical Trial
Updated: 12/31/1969
A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials